Evidence map›Paper›PMID 26483497›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Martijn H Brugman, Anna-Sophia Wiekmeijer, Marja van Eggermond, Ingrid Wolvers-Tettero, Anton W Langerak, Edwin F E de Haas, Leonid V Bystrykh, Jon J van Rood, Gerald de Haan, Willem E Fibbe and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Interrogation of clonal tracking data usingNature computational science · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Development of anFuture science OA · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Martijn H BrugmanDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; m.h.brugman@lumc.nl vanrood@europdonor.nl F.J.T.Staal@lumc.nl.
Anna-Sophia WiekmeijerDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands;
Marja van EggermondDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands;
Ingrid Wolvers-TetteroDepartment of Immunology, Erasmus University Medical Center, Rotterdam 3015 CE, The Netherlands;
Anton W LangerakDepartment of Immunology, Erasmus University Medical Center, Rotterdam 3015 CE, The Netherlands;
Edwin F E de HaasDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands;
Leonid V BystrykhDepartment of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Groningen 9713 AV, The Netherlands.
Jon J van RoodDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; m.h.brugman@lumc.nl vanrood@europdonor.nl F.J.T.Staal@lumc.nl.
Gerald de HaanDepartment of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Groningen 9713 AV, The Netherlands.
Willem E FibbeDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands;
Frank J T StaalDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; m.h.brugman@lumc.nl vanrood@europdonor.nl F.J.T.Staal@lumc.nl.
Leiden University Medical Center · NLErasmus MC · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fate and numbers of hematopoietic stem cells (HSC) and their progeny that seed the thymus constitute a fundamental question with important clinical implications. HSC transplantation is often complicated by limited T-cell reconstitution, especially when HSC from umbilical cord blood are used. Attempts to improve immune reconstitution have until now been unsuccessful, underscoring the need for better insight into thymic reconstitution. Here we made use of the NOD-SCID-IL-2Rγ(-/-) xenograft model and lentiviral cellular barcoding of human HSCs to study T-cell development in the thymus at a clonal level. Barcoded HSCs showed robust (>80% human chimerism) and reproducible myeloid and lymphoid engraftment, with T cells arising 12 wk after transplantation. A very limited number of HSC clones (<10) repopulated the xenografted thymus, with further restriction of the number of clones during subsequent development. Nevertheless, T-cell receptor rearrangements were polyclonal and showed a diverse repertoire, demonstrating that a multitude of T-lymphocyte clones can develop from a single HSC clone. Our data imply that intrathymic clonal fitness is important during T-cell development. As a consequence, immune incompetence after HSC transplantation is not related to the transplantation of limited numbers of HSC but to intrathymic events.

Indexed as

AnimalsBone Marrow CellsHumansMiceMice, Inbred NODMice, SCIDThymus GlandT-Lymphocyteshematopoietic stem cellT-cell developmentT-cell receptorthymusT lymphocyte

Identifiers

PMID26483497
PMCPMC4640754
OpenAlexW2142800370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.